Label-free single-cell phenotyping to determine tumor cell heterogeneity in pancreatic cancer in real time
Katja Wittenzellner(Pancreatic Cancer Action), Maximilian Reichert(German Cancer Research Center)
Cited by 3
Related Papers
Identification of treatment‐induced vulnerabilities in pancreatic cancer patients using functional model systems
|EMBO Molecular Medicine|2022|39
Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma
|Nature Biomedical Engineering|2024|32